POM-V Prescription Required

Fendicam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses

Active ingredient: Meloxicam

Form

Injection

Species

Cattle Horses Pigs

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/4090

What it's used for

Cattle: For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Fendicam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to
reduce clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to reduce
clinical signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with
antibiotic therapy.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of
lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia
(mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.

Revised: September 2021
AN: 02363/2020
Horses:
For use in the alleviation of inflammation and relief of pain in both acute and
chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic.

See also section 4.7.
Do not use in horses less than 6 weeks of age.
Do not use in animals suffering from impaired hepatic, cardiac or renal function
and haemorrhagic disorders, or where there is evidence of ulcerogenic
gastrointestinal lesions.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
For the treatment of diarrhoea in cattle, do not use in animals of less than one
week of age.

In cattle and pigs, subcutaneous, intramuscular as well as intravenous
administration is well tolerated; only a slight transient swelling at the injection
site following subcutaneous administration was observed in less than 10 % of
the cattle treated in clinical studies.
In horses, a transient swelling at the injection site can occur but resolves
without intervention.
In very rare cases anaphylactoid reactions, which may be serious (including
fatal), may occur and should be treated symptomatically.

None.

i) Special precautions for use in animals
If adverse reactions occur, treatment should be discontinued and the
advice of a veterinarian should be sought.
Avoid use in very severely dehydrated, hypovolaemic or hypotensive
animals which require parenteral rehydration, as there may be a
potential risk of renal toxicity.
In case of inadequate relief of pain when used in the treatment of equine
colic, careful re-evaluation of the diagnosis should be made as this could
indicate the need for surgical intervention.
ii) Special precautions for the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to non-steroidal anti-inflammatory
drugs (NSAIDs) should avoid contact with the veterinary medicinal
product.
Accidental self-injection may give rise to pain. In case of accidental self-
injection, seek medical advice immediately and show the package leaflet
or the label to the physician.
In view of the risk of accidental self-injection and the known adverse
class-effects of NSAIDs and other prostaglandin inhibitors on pregnancy
and/or embryofoetal development, the veterinary medicinal product
should not be administered by pregnant women or women attempting to
conceive.

Revised: September 2021
AN: 02363/2020
iii) Other precautions
None.

Do not administer concurrently with glucocorticosteroids, other NSAIDs or with
anti-coagulant agents.

This veterinary medicinal product does not require any special storage
conditions.

Cattle:
Meat and offal: 15 days.
Milk: 5 days (120 hours).
Pigs:
Meat and offal: 5 days
Horses:
Meat and offal: 5 days.
Not authorised for use in horses producing milk for human consumption.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.